FDA asks clinicians to monitor pharmaceutical companies’ marketing practices

Patient Safety Monitor Insider

June 2, 2010

The Food and Drug Administration (FDA) is asking for the help from clinicians in calling out unsafe marketing practices by pharmaceutical companies, according to American Medical News.

Although the FDA can track the messages pharmaceutical companies are putting out about new drugs via mainstream media like television commercials, pamphlets, and print advertisements, it has little power to know what is said behind closed doors at meetings with clinicians. Because of that, the FDA is reaching out to physicians, nurse practitioners, pharmacists, and physician assistants to monitor the marketing practices of pharmaceutical companies in private at meetings.

To read more from American Medical News, click here.